| Product Code: ETC7182693 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to receive significant imports of patient-derived xenograft (PDX) models, with top exporting countries being New Zealand, USA, Australia, India, and Taiwan, Province of China. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 experienced a sharp decline of -57.08%. This trend continued in 2024, with a growth rate of -57.1% compared to the previous year. These figures indicate a challenging market environment for PDX model imports in Fiji, suggesting potential shifts in the industry landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Patient Derived Xenograft (PDX) Models Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2022 & 2032F |
3.3 Fiji Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 Fiji Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2022 & 2032F |
3.7 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2022 & 2032F |
3.9 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Fiji Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision oncology |
4.2.2 Growing prevalence of cancer and the need for more effective treatment options |
4.2.3 Technological advancements in drug discovery and development processes |
4.3 Market Restraints |
4.3.1 High cost associated with the development and maintenance of patient-derived xenograft models |
4.3.2 Ethical concerns related to the use of animal models in research and drug development |
5 Fiji Patient Derived Xenograft (PDX) Models Market Trends |
6 Fiji Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 Fiji Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2022 - 2032F |
6.1.4 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2022 - 2032F |
6.2 Fiji Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2022 - 2032F |
6.2.3 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2022 - 2032F |
6.2.4 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2022 - 2032F |
6.3 Fiji Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2022 - 2032F |
6.3.3 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2022 - 2032F |
6.3.4 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2022 - 2032F |
6.3.5 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2022 - 2032F |
6.3.6 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2022 - 2032F |
6.3.7 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2022 - 2032F |
6.4 Fiji Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2022 - 2032F |
6.4.3 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2022 - 2032F |
6.5 Fiji Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2022 - 2032F |
6.5.3 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.5.4 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2022 - 2032F |
6.5.5 Fiji Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2022 - 2032F |
7 Fiji Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 Fiji Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 Fiji Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 Fiji Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Average time required for drug screening using patient-derived xenograft models |
8.2 Number of research publications citing the use of Fiji patient-derived xenograft models |
8.3 Adoption rate of patient-derived xenograft models in preclinical drug development studies. |
9 Fiji Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 Fiji Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Fiji Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2022 & 2032F |
9.3 Fiji Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Fiji Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2022 & 2032F |
9.5 Fiji Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Fiji Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 Fiji Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2025 |
10.2 Fiji Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here